SCHEMBL5203594

SCHEMBL5203594

COC(=O)c1cc(Br)nc(Br)c1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.43
KDM4E B2RXH2 5/20 0.42
ALDH1A1 P00352 2/20 0.42
KMT2A Q03164 2/20 0.40
GAA P10253 1/20 0.39
HPGD P15428 1/20 0.39
MAPT P10636 2/20 0.38
NPSR1 Q6W5P4 1/20 0.38
CA12 O43570 2/20 0.37
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37
CA7 P43166 2/20 0.37
CA9 Q16790 2/20 0.37
CA14 Q9ULX7 2/20 0.37
PDK2 Q15119 1/20 0.37
PDK4 Q16654 1/20 0.37
NR4A2 P43354 1/20 0.36
XDH P47989 1/20 0.36
CYP46A1 Q9Y6A2 1/20 0.36
ATM Q13315 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31267853 0.83 L3MBTL1 (0.41) L3MBTL1KDM4EALDH1A1KMT2AGAA
SCHEMBL38664397 0.83 ALDH1A1 (0.46) L3MBTL1KDM4EALDH1A1KMT2AMAPT
SCHEMBL31264183 0.81 KDM4E (0.46) L3MBTL1KDM4EALDH1A1GAAHPGD
SCHEMBL143872 0.81 KDM4E (0.46) L3MBTL1KDM4EALDH1A1GAAHPGD
SCHEMBL9069965 0.76 KDM4E (0.44) L3MBTL1KDM4EALDH1A1KMT2AGAA
SCHEMBL22658874 0.74 L3MBTL1 (0.45) L3MBTL1KDM4EALDH1A1KMT2AGAA
SCHEMBL29587479 0.74 L3MBTL1 (0.45) L3MBTL1KDM4EALDH1A1KMT2AGAA
SCHEMBL21713467 0.71 L3MBTL1 (0.40) L3MBTL1KDM4EALDH1A1KMT2AGAA
SCHEMBL31184683 0.71 KDM4E (0.45) KDM4EALDH1A1GAAMAPTCYP46A1
SCHEMBL26987484 0.71 KDM4E (0.45) KDM4EALDH1A1GAAMAPTCYP46A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1290448-B1 RARE EARTH METAL CRYPTATES SHOWING REDUCED FLUORESCENCE QUENCHING CIS BIO INT (FR) 2007-11-07 EP disclosed
US-7087384-B2 Rare earth metal cryptates which are not very sensitive to the fluorescence quenching CIS BIO INTERNATIONAL (FR) 2006-08-08 US disclosed
US-20040092726-A1 Novel rare earth metal cryptates which are not very sensitive to the fluorescence quenching CIS BIO INTERNATIONAL (FR) 2004-05-13 US disclosed
EP-1290448-A2 RARE EARTH METAL CRYPTATES SHOWING REDUCED FLUORESCENCE QUENCHING CIS BIO INTERNATIONAL (FR) 2003-03-12 EP disclosed
WO-2001096877-A2 RARE EARTH METAL CRYPTATES SHOWING REDUCED FLUORESCENCE QUENCHING CIS BIO INTERNATIONAL (FR) 2001-12-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040092726-A1 Novel rare earth metal cryptates which are not very sensitive to the fluorescence quenching SQOR, MCU, NDUFS4 L3MBTL1 3443/4885KDM4E 3781/4885ALDH1A1 2119/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.